B
Black Diamond Therapeutics D
D
BDTX
2.76000
USD
-0.02
(-0.54%)
مغلق
حجم التداول
30,715
الربح لكل سهم
0
العائد الربحي
-
P/E
12
حجم السوق
157,141,370
العنوان: Black Diamond Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.